In line with these findings, our research indicates that COL11A1 mRNA levels are capable of distinguishing between normal breast tissue, benign tumors, and cancerous tissues, hinting at its utility as an adjunct molecular marker for breast cancer diagnosis. The gene discussed is COL11A1; the disease is benign neoplasm.